Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy

NCT02679040 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT02679040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy
Lead sponsor
Institut Paoli-Calmettes
Phase
Phase 2
Overall status
Unknown status
Start date
January 27, 2016
Completion date
February 28, 2025
Enrollment
101 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer